Risk
5/12/2010
07:07 PM
Connect Directly
LinkedIn
Twitter
Google+
RSS
E-Mail
50%
50%

Canadian Admits Selling Fake Cancer Drugs Online

The scammer faces up to 20 years in prison for wire fraud.

A 22-year-old Canadian man pleaded guilty on Tuesday in Phoenix, Arizona, to selling fake cancer drugs over the Internet.

Hazim Gaber, a resident of Edmonton, Canada, was indicted last year on five counts of wire fraud, according to the Department of Justice. He was arrested in Germany in 2009 and extradited to the U.S.

At his plea hearing, Gaber acknowledged selling what he claimed was the experimental cancer drug sodium dichloroacetate, or DCA, to at least 65 people in the Belgium, Canada, the Netherlands, the U.K., and the U.S.

Court documents state that "DCA is an odorless, inexpensive, relatively non-toxic experimental cancer drug that is highly sought after by cancer patients."

DCA is not approved by the FDA and is only available to patents in clinical trials.

What Gaber provided to customers, however, was not DCA. It was, he acknowledged, various common white powdery substances such as starch, dextrin, dextrose, or lactose.

A Department of Justice spokesperson did not immediately respond to a request for information about the extent to which the cancer patients who took the fake DCA suffered harm as a result of being duped.

Gaber also acknowledged that his Web site, DCAdvice.com, included false claims that the site was the only lawful supplier of DCA and that the site was affiliated with the University of Alberta.

The doctor who published the 2007 study that suggested DCA's effectiveness as a cancer treatment, Evangelos Michelakis, is a professor in the University's Department of Medicine.

In his plea, Gaber also admitted to selling more than 800 copies of pirated business software.

Gaber faces up to 20 years in prison and a fine of $250,000 for each count of wire fraud. His sentencing is scheduled for August 2.

Comment  | 
Print  | 
More Insights
Register for Dark Reading Newsletters
White Papers
Cartoon
Current Issue
Flash Poll
Video
Slideshows
Twitter Feed
Dark Reading - Bug Report
Bug Report
Enterprise Vulnerabilities
From DHS/US-CERT's National Vulnerability Database
CVE-2014-3345
Published: 2014-08-28
The web framework in Cisco Transport Gateway for Smart Call Home (aka TG-SCH or Transport Gateway Installation Software) 4.0 does not properly check authorization for administrative web pages, which allows remote attackers to modify the product via a crafted URL, aka Bug ID CSCuq31503.

CVE-2014-3347
Published: 2014-08-28
Cisco IOS 15.1(4)M2 on Cisco 1800 ISR devices, when the ISDN Basic Rate Interface is enabled, allows remote attackers to cause a denial of service (device hang) by leveraging knowledge of the ISDN phone number to trigger an interrupt timer collision during entropy collection, leading to an invalid s...

CVE-2014-4199
Published: 2014-08-28
vm-support 0.88 in VMware Tools, as distributed with VMware Workstation through 10.0.3 and other products, allows local users to write to arbitrary files via a symlink attack on a file in /tmp.

CVE-2014-4200
Published: 2014-08-28
vm-support 0.88 in VMware Tools, as distributed with VMware Workstation through 10.0.3 and other products, uses 0644 permissions for the vm-support archive, which allows local users to obtain sensitive information by extracting files from this archive.

CVE-2014-0761
Published: 2014-08-27
The DNP3 driver in CG Automation ePAQ-9410 Substation Gateway allows remote attackers to cause a denial of service (infinite loop or process crash) via a crafted TCP packet.

Best of the Web
Dark Reading Radio
Archived Dark Reading Radio
This episode of Dark Reading Radio looks at infosec security from the big enterprise POV with interviews featuring Ron Plesco, Cyber Investigations, Intelligence & Analytics at KPMG; and Chris Inglis & Chris Bell of Securonix.